Ob/Gyn Articles

Ob/Gyn

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Petraglia F et al. - Serum follistatin is increased in women with endometriosis and allows clear distinction between endometrioma and other benign ovarian cysts. Follistatin has the sensitivity and specificity to become a useful clinical marker of ovarian endometrioma.

Related Articles

Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis
International Journal of Clinical Oncology, 11/02/09    Relevance Score: 69%

Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis
Fertility and Sterility, 10/14/09    Relevance Score: 68%

Recurrence rate of endometrioma after laparoscopic cystectomy: A comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo
European Journal of Obstetrics & Gynecology and Reproductive Biology, 10/22/09    Relevance Score: 67%

Endometriosis and in vitro fertilisation
Gynecological Endocrinology, 10/29/09    Relevance Score: 66%

Anti muellerian hormone serum levels in women with endometriosis: A case-control study
Gynecological Endocrinology, 10/29/09    Relevance Score: 66%

Today in Radiology/Diagnostics...keeping you current

Papillary squamous intraepithelial lesions of the uterine cervix: human papillomavirus-dependent changes in cell cycle expression and cytologic features
Human Pathology, 12/07/09

Fetal growth screening by fundal height measurement
Best Practice & Research Clinical Obstetrics & Gynaecology, 12/07/09

Sonographic Changes after Removing All Benign Breast Masses with Sonographically Guided Vacuum-Assisted Biopsy
Acta Radiologica, 12/07/09